Andrew Huberman is joining Hims.
He will advise the company on science and brand marketing and provide separate marketing support through his podcast.
That puts one of health podcasting's biggest voices in the boardroom of a company that can sell many of the treatments he discusses. Hims & Hers is expanding from hair loss and erectile dysfunction into weight loss, testosterone, preventive care and peptides, according to Business Insider.
Huberman says that won't change what he says on air. "We will never filter information differently because of a brand relationship," he told Business Insider.
The company framed the appointment around his science credentials. Hims & Hers CEO Andrew Dudum said in the company's announcement that Huberman "has done more than almost anyone to make rigorous science accessible and actionable for millions of people." The announcement says Huberman has written or co-written more than 75 peer-reviewed articles and calls Huberman Lab the most popular health and science podcast in the world.
Huberman told Business Insider he first reached out to Dudum through a mutual friend, and the two spent six to eight months discussing the future of consumer healthcare. He said he sees Hims filling "this enormous gap that's existed in the middle" between the traditional healthcare system and high-end concierge care. "The middle 95%" should be able to access personalized care, he said.
Peptides are a big part of the picture. Business Insider reports that Hims signed a deal for a California peptide facility at the end of 2024 and announced the acquisition in February 2025. The company recently previewed Peptides+, a section of its website where consumers will be able to access peptides such as BPC-157 once regulatory approval permits.
Huberman has been one of the most prominent mainstream voices discussing injectable peptides, per Business Insider. "I don't know if somebody without an injury needs BPC and TB-500," he said.
Huberman's media company, Scicomm Media, will run podcast ads for Hims & Hers and receive payment in exchange, Business Insider reports. Huberman did not specify how each podcast episode, social post or short clip will disclose his board seat and separate marketing relationship with the company.
Business Insider notes that his earlier advisory work with fitness and sleep brands was different, because a board seat comes with fiduciary duties and a hand in company strategy. The independence pledge is Huberman's own, and the disclosure details haven't been spelled out yet.
"You have to be a channel, not a dam to this kind of information," Huberman said.